You are here

Novartis

Two Novartis sites stop manufacturing cancer therapies after quality issues

Endpoints

Thu, 05/5/22 - 11:21 pm

drug manufacturing

Record-breaking 2021 revenue shows there's more to Swiss biotech sector than Roche, Novartis

Fierce Biotech

Wed, 05/4/22 - 10:30 am

Sophia Genetics

CRISPR Therapeutics

Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?

Motley Fool

Mon, 05/2/22 - 11:57 am

The Medicines Company

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

BioSpace

Wed, 04/27/22 - 10:59 am

A bad day for Molecular Partners

EP Vantage

Wed, 04/27/22 - 10:45 am

Molecular Partners

Novartis records another tislelizumab win en route to bringing BeiGene's PD-1 to FDA's doors

Endpoints

Wed, 04/27/22 - 10:32 am

esophageal cancer

Novartis confirms 'thousands' of layoffs loom as its global reorganization rolls ahead

Fierce Pharma

Tue, 04/26/22 - 10:38 pm

Novartis income edges higher on strong Sandoz, Entresto

Yahoo/Reuters

Tue, 04/26/22 - 10:23 am

Pharma Continues to Support Ukraine as War Rages On

BioSpace

Fri, 04/22/22 - 10:40 am

Thousands of layoffs planned as part of Novartis restructuring — report

Endpoints

Tue, 04/12/22 - 11:02 am

Novartis Highlights Early Data from Potential Lumakras Competitor at AACR

BioSpace

Tue, 04/12/22 - 10:49 am

clinical trials

Novartis' PI3K drug, already approved in breast cancer, nabs a speedy OK to treat ultra-rare condition

Endpoints

Wed, 04/6/22 - 12:01 pm

real world evidence

Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies

Endpoints

Tue, 04/5/22 - 11:33 pm

ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late

EP Vantage

Tue, 04/5/22 - 10:59 am

Ionis Pharmaceuticals

In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs

Fierce Pharma

Mon, 04/4/22 - 11:00 am

Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients

Endpoints

Wed, 03/23/22 - 11:01 pm

prostate cancer

Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week

Fierce Pharma

Wed, 03/23/22 - 10:58 pm

product recalls

Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024

Fierce Pharma

Wed, 03/23/22 - 10:38 am

Novartis takes next step in Russia, halting new trials and enrollment as Big Pharma responds to Ukraine invasion

Endpoints

Tue, 03/22/22 - 10:39 am

clinical trials

Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?

Motley Fool

Sun, 03/20/22 - 11:03 pm

Voyager Therapeutics

Pages